82 results
8-K
EX-99.1
RVMD
Revolution Medicines Inc
9 Jan 24
Results of Operations and Financial Condition
2:15pm
leading to treatment discontinuation) No fatal TRAEs were observed. Two patients discontinued study treatment due to death: one patient with PDAC (120 mg
8-K
EX-99.1
41ldtusnujzarz55l
23 Oct 23
Regulation FD Disclosure
6:11am
8-K
35zv85iu0qoys3is2x2b
13 Oct 23
Other Events
11:54am
DEFM14A
d7vpn1zs8p arj9ez18
29 Sep 23
Proxy related to merger
4:19pm
424B3
9b6mmxi97h2y1 whla
29 Sep 23
Prospectus supplement
4:17pm
S-4/A
2da367cpnbal9unv
27 Sep 23
Registration of securities issued in business combination transactions (amended)
5:25pm
S-4
3xuz 6dem5hpt
13 Sep 23
Registration of securities issued in business combination transactions
5:20pm
425
31genl3 4d
1 Aug 23
Business combination disclosure
5:22pm
425
ay05qy1
1 Aug 23
Business combination disclosure
7:15am
8-K
EX-10.2
zavz3yz
1 Aug 23
Form of Parent Stockholder Voting Agreement
7:10am
8-K
EX-2.1
w5wj303v3gk9k75b
1 Aug 23
Form of Parent Stockholder Voting Agreement
7:10am